Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Beyond GLP-1, the market encompasses peptide cancer therapies (Oncology Peptide Therapy at 4.1% share, 11.79% CAGR), somatostatin analogues for neuroendocrine tumours, GnRH agonists/antagonists for hormone-sensitive cancers, radioligand therapy, and reproductive medicine peptides each representing strategically important niches with their own competitive dynamics
However, if patients are fully committed, they can achieve much more significant results. In a 2022 study, researchers monitored the weight loss of 175 patients who were overweight or obese and were taking semaglutide injections
That is a clean story
AOD 9604, a synthetic analog of the human growth hormone, or HGH, is one of the most researched types
US$ 21.29
US$ 25.93
US$ 20.06
US$ 28.49
US$ 27.21
US$ 21.43
US$ 27.33
